3 results on '"Laguno, M"'
Search Results
2. Direct‐acting antivirals are effective and safe in HCV/HIV‐coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study
- Author
-
Manzardo, Christian, Londoño, Maria C., Castells, LLuís, Testillano, Milagros, Luis Montero, José, Peñafiel, Judit, Subirana, Marta, Moreno, Ana, Aguilera, Victoria, Luisa González‐Diéguez, María, Calvo‐Pulido, Jorge, Xiol, Xavier, Salcedo, Magdalena, Cuervas‐Mons, Valentin, Manuel Sousa, José, Suarez, Francisco, Serrano, Trinidad, Ignacio Herrero, Jose, Jiménez, Miguel, Fernandez, José R., Giménez, Carlos, del Campo, Santos, Esteban‐Mur, Juan I., Crespo, Gonzalo, Moreno, Asunción, de la Rosa, Gloria, Rimola, Antoni, Miro, Jose M., Suárez, F., Castro, M.A., López, S., Pedreira, J.D., Vázquez, P., Agüero, F., Blanch, J., Brunet, M., Calatayud, D., Cervera, C., Lazzari, E., Fondevila, C., Forner, A., Fuster, J., Forns, X., Gil, A., Gatell, J.M., Laguno, M., Lligoña, A., Mallolas, J., Murillas, J., Navasa, M., Paredes, D., Pérez, I., Torres, F., Tural, C., Tuset, M., Antela, A., Losada, E., Molina, E., Otero, E., Varo, E., Araiz, J.J, Barrao, E., Larraga, J., Letona, S., Lozano, R., Luque, P., Navarro, A., Sanjoaquín, I., Tejero, E., Bañares, R., Berenguer, J., Clemente, G., Cosín, J., Ferreiroa, J.P, García‐Sabrido, J.L., Gutiérrez, I., López, J.C., Miralles, P., Ramírez, M., Rincón, D., Sánchez, M., Cruz, J., Fernández, J.L., Lozano, J.M., Santoyo, J., Rodrigo, J.M., Suárez, M.A., Rodríguez, M., Alonso, M.P., Asensi, V., González‐Pinto, I., Rafecas, A., Baliellas, C., Carratalá, J., Fabregat, J., Fernández, N., Jorba, R., Lladó, L., Montejo, M., Bustamante, J., Fernández, J.R., Gastaca, M., González, J., Montejo, E., Ortiz de Urbina, J., Ruiz, P., Suárez, M.J., Valdivieso, A., Ventoso, A., Abradelo, M., Calvo, J., Costa, J.R., García‐Sesma, A., Jiménez, C., Manrique, A., Meneu, J.C., Moreno, E., Moreno, V., Olivares, S.P., Pulido, F., Rubio, R., Blanes, M., Berenguer, M., López, J., López, R., Prieto, M., Fariñas, M.C., Casafont, F., Echevarria, S., Fábrega, E., Gomez‐Fleitas, M., Armiñanzas, C., Herrera‐Noreña, J.L., Moreno, S., Barcena, R., Fortún, J., Moreno, A.M., Martín‐Dávila, P., Torre‐Cisneros, J., Barrera, P., Briceño, J., Caston, J.J., Costan, G., Mata, M., Lara, R., López‐Cillero, P., Rivero, A., Rufian, S., Sánchez‐Antolín, G., García Pajares, F., Bachiller, P., Almohalla, C., Barrera, A., Conde, R., Bilbao, I., Campos‐Varela, I., Charco, R., Esteban, J.I., Gavaldá, J., Len, O., Pahissa, A., Ribera, E., Vargas, V., Pons, J.A., Cordero, E., Bernal, C., Cisneros, J.M., Gómez, M.A., Pascasio, J.M., Rodríguez, M.J., Sayago, M., Suárez, G., González‐García, J., Aznar, E., Esteban, H., Moyano, B., Garrido, G., Mahillo, B., Matesanz, R., Guerra, L., Manzanera, M., and Samuel, D.
- Abstract
Direct‐acting antivirals have proved to be highly efficacious and safe in monoinfected liver transplant (LT) recipients who experience recurrence of hepatitis C virus (HCV) infection. However, there is a lack of data on effectiveness and tolerability of these regimens in HCV/HIV‐coinfected patients who experience recurrence of HCV infection after LT. In this prospective, multicenter cohort study, the outcomes of 47 HCV/HIV‐coinfected LT patients who received DAA therapy (with or without ribavirin [RBV]) were compared with those of a matched cohort of 148 HCV‐monoinfected LT recipients who received similar treatment. Baseline characteristics were similar in both groups. HCV/HIV‐coinfected patients had a median (IQR) CD4 T‐cell count of 366 (256‐467) cells/µL. HIV‐RNA was <50 copies/mL in 96% of patients. The DAA regimens administered were SOF + LDV ± RBV (34%), SOF + SMV ± RBV (31%), SOF + DCV ± RBV (27%), SMV + DCV ± RBV (5%), and 3D (3%), with no differences between the groups. Treatment was well tolerated in both groups. Rates of SVR (negative serum HCV‐RNA at 12 weeks after the end of treatment) were high and similar for coinfected and monoinfected patients (95% and 94%, respectively; P= .239). Albeit not significant, a trend toward lower SVR rates among patients with advanced fibrosis (P= .093) and genotype 4 (P= .088) was observed. In conclusion, interferon‐free regimens with DAAs for post‐LT recurrence of HCV infection in HIV‐infected individuals were highly effective and well tolerated, with results comparable to those of HCV‐monoinfected patients. Direct‐acting antivirals against HCV offer a very high and similar efficacy and safety in HIV‐positive and HIV‐negative liver transplant recipients.
- Published
- 2018
- Full Text
- View/download PDF
3. Congenital and metabolic myopathies of childhood or adult onset
- Author
-
Miro, O., Laguno, M., Masanes, F., Perea, M., Urbano-Marquez, A., and Grau, J.M.
- Abstract
Objectives:: To investigate the clinical presentation, histological findings, and outcome of patients with congenital and metabolic myopathies (CM and MM) in whom the disease was diagnosed in childhood or adulthood. Patients and Methods:: We reviewed the diagnosis of all skeletal muscle biopsies performed by our group between 1984 and 1996 (13 years). All patients with CM and MM of childhood or adult onset were included in the study. Patients with mitochondrial myopathies were excluded because they are multisystemic disorders with a more distinct picture than that observed in other MM. We retrospectively reviewed the clinical history, with special emphasis on the clinical patterns of presentation, histological findings, and outcome. Results:: Among 1,865 biopsies, 28 (1.5%) fulfilled the diagnostic criteria for CM(seven nemaline myopathies, four multicore myopathies, three centronuclear myopathies) or MM (five adult-onset acid maltase deficiency, three myophosphorylase deficiency, three phosphofructokinase deficiency, two carnitine palmitoyl transferase deficiency, and one carnitine deficiency). In nearly half of the patients, mild stable weakness was the major complaint, whereas in one third muscular symptoms were intermittent and related to exercise. In a small number of cases, a persistently raised serum creatinkinase in an asymptomatic patient was the reason for muscle biopsy. Histological examination of skeletal muscle was highly indicative of a specific muscle disease in 26 of the 28 cases. After a mean follow-up of 7 years, the outcome has generally been good, and in most patients the myopathy did not worsen, most remaining ambulatory. Conclusion:: CM and MM presenting in childhood or adulthood are infrequent; the symptoms are usually mild or moderate, and the prognosis generally is good.
- Published
- 2000
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.